KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $45,354,000 | +6.8% | 252,234 | -38.4% | 0.05% | +4.5% |
| Q2 2017 | $42,474,000 | +11.8% | 409,707 | -15.4% | 0.04% | +12.8% |
| Q1 2017 | $37,998,000 | +43.5% | 484,109 | -18.0% | 0.04% | +34.5% |
| Q4 2016 | $26,471,000 | +36.9% | 590,343 | +70.5% | 0.03% | +38.1% |
| Q3 2016 | $19,337,000 | +28.8% | 346,171 | +15.3% | 0.02% | +23.5% |
| Q2 2016 | $15,008,000 | +15.3% | 300,160 | +5.8% | 0.02% | +13.3% |
| Q1 2016 | $13,020,000 | -26.0% | 283,601 | -0.7% | 0.02% | -28.6% |
| Q4 2015 | $17,595,000 | +16.5% | 285,536 | +5.3% | 0.02% | +16.7% |
| Q3 2015 | $15,104,000 | -6.0% | 271,266 | +3.0% | 0.02% | 0.0% |
| Q2 2015 | $16,060,000 | – | 263,415 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |